For the quarter ending 2026-03-31, XBIT has $139,836K in assets. $4,819K in debts. $115,459K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Accrued interest receivable | - | - | 450 | 480 |
| Income tax receivable | - | 0 | 75 | 158 |
| Cash and cash equivalents | 115,459 | 125,551 | 147,367 | 152,938 |
| Accrued interest receivable | 302 | 360 | - | - |
| Prepaid expenses and other current assets | 1,288 | 1,042 | 1,059 | 1,313 |
| Total current assets | 117,049 | 126,953 | 148,951 | 154,889 |
| Property and equipment, net | 22,787 | 23,129 | 23,473 | 23,793 |
| Total assets | 139,836 | 150,082 | 172,424 | 178,682 |
| Accounts payable | 857 | 1,535 | 1,043 | 1,431 |
| Convertible loan-Related Party | - | 0 | 0 | 0 |
| Convertible loan-Nonrelated Party | - | 0 | 0 | 0 |
| Accrued expenses | 2,035 | 6,318 | 2,422 | 2,410 |
| Income tax payable | 107 | 76 | 100 | 16 |
| Total current liabilities | 2,999 | 7,929 | 3,565 | 3,857 |
| Income tax payable | 1,815 | 1,798 | 1,779 | 1,761 |
| Deferred tax liability | 5 | 5 | - | - |
| Total liabilities | 4,819 | 9,732 | 5,344 | 5,618 |
| Preferred stock, no par value, unlimited shares authorized, no shares outstanding | 0 | 0 | 0 | 0 |
| Common stock, no par value, unlimited shares authorized, 30,487,731 shares issued and outstanding at march 31, 2026 and december 31, 2025 | 276,899 | 276,727 | 276,565 | 276,541 |
| Accumulated deficit | -141,882 | -136,377 | -109,485 | -103,477 |
| Total shareholders equity | 135,017 | 140,350 | 167,080 | 173,064 |
| Total liabilities and shareholders equity | 139,836 | 150,082 | 172,424 | 178,682 |
XBiotech Inc. (XBIT)
XBiotech Inc. (XBIT)